Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-543-6420
Fax+1 608-890-7127
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Elizabeth Duke, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Wisconsin.
Education & Training
University of WashingtonFellowship, Infectious Disease, 2017
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2010 - 2013
Marshall University Joan C. Edwards School of MedicineClass of 2010
Certifications & Licensure
WA State Medical License 2014 - 2025
WI State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation.Danniel Zamora, Hu Xie, Alicja Sadowska-Klasa, Eleftheria Kampouri, Melinda A Biernacki
Blood Advances. 2024-09-10 - 5 citationsDynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective obs...Maria Salgado, Cristina Gálvez, Monique Nijhuis, Mi Kwon, E Fabian Cardozo-Ojeda
The Lancet. HIV. 2024-06-01 - 8 citationsStochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation.Stefan Radtke, Mark Enstrom, Dnyanada Pande, Elizabeth R Duke, E Fabian Cardozo-Ojeda
Blood. 2023-07-06
Press Mentions
What You Need to Know About Access to COVID Antiviral Drugs and Therapeutics in King County and WAJune 13th, 2022- Can These Drugs Stop a COVID Infection in Its Tracks? Seattle Researchers Are on the Forefront of New TreatmentsJune 13th, 2022
- Merck Says It Has the First Antiviral Pill Found to Be Effective Against CovidOctober 1st, 2021
